MP-0310

N/A

Report date: 2022/01/20 14:43:56

Base Information

Drug NameMP-0310
Drug Alias NameFAP x 4-1BB4-1BB/FAP bispecific DARPinMP-0310AMG-506
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsT lymphocytes stimulantsFibroblast activation protein alpha antagonists
TargetsTumor necrosis factor receptor superfamily member 9Prolyl endopeptidase FAP
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMolecular Partners AgAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesMolecular Partners AgBeOne Medicines LtdAmgen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A